• Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Vetoquinol SA

+ Add to Watchlist

VETO:FP

36.5000 EUR 1.5000 4.29%

As of 07:07:19 ET on 09/22/2014.

Snapshot for Vetoquinol SA (VETO)

Open: 36.0000 Day's Range: 35.6600 - 36.6500 Volume: 7,771
Previous Close: 35.0000 52wk Range: 27.4000 - 40.0000 1-Yr Rtn: +33.42%

Stock Chart for VETO

No chart data available.
  • VETO:FP 36.5000
  • 1D
  • 1M
  • 1Y
35.0000
Interactive VETO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VETO

Current P/E Ratio (ttm) 18.0247
Estimated P/E(12/2014) 17.1362
Relative P/E vs. CAC 0.6932
Earnings Per Share (EUR) (ttm) 2.0250
Est. EPS (EUR) (12/2014) 2.1300
Est. PEG Ratio -
Market Cap (M EUR) 433.69
Shares Outstanding (M) 11.88
30 Day Average Volume 2,468
Price/Book (mrq) 1.8449
Price/Sale (ttm) 1.4310
Dividend Indicated Gross Yield 1.01%
Cash Dividend (EUR) 0.3700
Dividend Ex-Date 06/02/2014
5 Year Dividend Growth 6.50%
Next Earnings Announcement 03/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VETO

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for VETO

Vetoquinol S.A. is an independent veterinary pharmaceutical laboratory serving both the companion and production animal markets. The Company operates in the research and development, production and marketing of medical and non-medical products in areas such as anti-infectives, pain/inflammation and cardiology/ nephrology.

Etienne FrechinChairmanMatthieu FrechinChief Executive Officer
Jean-Yves RavinetCo-COOAlain MassonCo-COO
More Company Profile & Key Executives for VETO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil